Buy Legal Nootropic Supplement Compound 7p For Cranial Nerve Damaged Repairment (CAS 1890208-58-8)
Compound 7p Description
Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.
Here we report phenotypic cell-based screen of chemical libraries and structure-activity-guided optimization that resulted in the identification of compound 7p which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina.
In an animal model of optic nerve injury, compound 7p was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p translates into stimulation of axon regeneration in vivo.further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.
Compound 7p Basic Information
Name: Compound 7p
Chemical name: 2-[2-Methoxyphenyl)[4-methylpheny)sulfonyl]-N-(4-methoxy-3-pyridiny)acetamide Reaxys Registry Number:29568294
CAS: 1890208-58-8
Purity: 99%
Appearance: white powder
MF: C22H23N3O5S
Linear Structure Formula: C22H23N3O5S
MW: 441.508
Compound 7p Certificate Of Analysis
Product name |
Compound 7p |
CAS No. |
1890208-58-8 |
Outer Packing |
25kg/drum |
Production date |
18th Jan 2018 |
Shelf life |
17th Jan 2020 |
Standard adopted |
Complies with the requirements of SFDA of China |
Items of analysis |
Specification |
Results |
Appearance |
White crystalline powder |
Complies |
Solubility |
Soluble in ethyl acetate, dichloromethan, slightly soluble in methanol, insoluble in water |
Complies |
Related substances(hplc) |
Any single impurity≤0.5%
Total impurities≤1% |
0.21%
0.43% |
Loss on drying |
≤0.5% |
Complies |
Conclusion |
Qualified |